Sponsored Links
  • Medtronic 1300x380
  • EigenFlow 2 Advanced 1300x380
  • VitalGo Systems 1300x380
  • HESC Sponsors Ad 1300x380 CLR Essential Pharma
  • Abbott 1300x380
  • ODI Orthodynamics Company 1300x380
  • Grifols 1300x380
  • HESC Sponsors Ad 1300x380 Abbot Indiana Donor Network
  • HESC Sponsors Ad 1300x380 Abiomed Biomed Simulation

Caution in Using Activated Partial Thromboplastin Time to Monitor Argatroban

Susan Guy and colleagues recently published a research paper, “Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT),” in Clinical and Applied Thombosis/Hemostasis. Here we summarize their work. Argatroban is approved for the treatment of patients with heparin-induced thrombocytopenia (HIT), Vaccine-induced Immune Thrombocytopenia (VITT),…

Login in to view this article:

You need to be logged in to view the rest of this article. Don't have an account? Register for one below.

Notify of

Inline Feedbacks
View all comments
Sponsored Links
  • Beating Heart Newsletter Ad
  • EigenFlow 2 Advanced 800x800
  • HBP Place Ad Here

Stay Informed! Sign up for our newsletter.

Stay informed with new article notifications and updates. Your email is used for article notification and update purposes only and will never be used for spam.

Would love your thoughts, please comment.x